- Home
- OLPX vs BBOT Comparison
OLPX vs BBOT Comparison
Compare OLPX & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLPX | BBOT |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 941.2M | 1.1B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | OLPX | BBOT |
|---|---|---|
| Price | $1.51 | $10.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $1.69 | ★ $23.83 |
| AVG Volume (30 Days) | ★ 1.4M | 320.5K |
| Earning Date | 03-03-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $418,582,000.00 | N/A |
| Revenue This Year | $1.80 | N/A |
| Revenue Next Year | $2.51 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.99 | $8.50 |
| 52 Week High | $1.84 | $14.87 |
Technical Indicators
Market Signals| Indicator | OLPX | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 50.45 | 36.75 |
| Support Level | $1.49 | $10.08 |
| Resistance Level | $1.63 | $12.01 |
| Average True Range (ATR) | 0.08 | 0.87 |
| MACD | -0.02 | -0.21 |
| Stochastic Oscillator | 20.59 | 3.58 |
Price Performance
Historical ComparisonAbout OLPX Olaplex Holdings Inc.
Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.